Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum TripSitter Clinic Ltd C.KETA

Alternate Symbol(s):  TSTTF

TripSitter Clinic Ltd. is a Canada-based company. The Company has no active business.

CSE:KETA - Post Discussion

TripSitter Clinic Ltd > $KETA - Dually Listed on Frankfurt Stock Exchange
View:
Post by firstandgoal43 on Jan 10, 2022 6:19pm

$KETA - Dually Listed on Frankfurt Stock Exchange

$KETA huge new announcement that they will be dual listing on the Frankfurt Stock Exchange. The stock has already started trading under the symbol “UY0” and is starting to gain momentum. At the same time the company seems really excited to appoint Richard Dolan to its BOD and I expect to see the share price reflect their excitement to the public. Love where this one is at rn at 0.32, good market cap and a growing industry

 
Comment by StockHawk1 on Jan 12, 2022 6:33pm
You were totally correct that this cross-listing and the excitement around it would positively reflect the share price. $KETA went up almost 10% today. Only a couple of days on the FSE and we are already seeing this price leap. Closed today at $0.35
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities